Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) Total Liabilities : ¥2,914 Mil (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co Total Liabilities?

Hebei Changshan Biochemical Pharmaceutical Co's Total Liabilities for the quarter that ended in Sep. 2024 was ¥2,914 Mil.

Hebei Changshan Biochemical Pharmaceutical Co's quarterly Total Liabilities increased from Mar. 2024 (¥2,932.44 Mil) to Jun. 2024 (¥3,022.28 Mil) but then declined from Jun. 2024 (¥3,022.28 Mil) to Sep. 2024 (¥2,914.34 Mil).

Hebei Changshan Biochemical Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (¥2,117.73 Mil) to Dec. 2022 (¥2,981.78 Mil) but then declined from Dec. 2022 (¥2,981.78 Mil) to Dec. 2023 (¥2,796.76 Mil).

Hebei Changshan Biochemical Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co Total Liabilities Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,220.32

1,719.33

2,117.73

2,981.78

2,796.76

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															2,775.77	2,796.76	2,932.44	3,022.28	2,914.34

Hebei Changshan Biochemical Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hebei Changshan Biochemical Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1920.921	+	(813.016	+	62.825
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,797

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	4596.454	-	1799.692
	=	2,797

Hebei Changshan Biochemical Pharmaceutical Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1974.421	+	(766.45	+	46.689
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2,914

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	4686.232	-	1771.888
	=	2,914

Hebei Changshan Biochemical Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hebei Changshan Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800

Website

http://www.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.

Executives

Li Zhi Hua	Executives
Wang Jun	Executives
Ding Jian Wen	Directors, executives
Huang Guo Sheng	Executives
Gao Shu Hua	Directors, executives
Chen Xi	Director
Cai Hao	Executives
Ji Sheng Li	Directors, executives
Li Xin	Securities Affairs Representative
Zhang Wei	Secretary Dong
Liu Jian	Executives
Zhang Zhi Ying	Executives
Guo Yan Xing	Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines